Aurora Cannabis (TSE:ACB) Shares Down 2.5% – What’s Next?

Aurora Cannabis Inc. (TSE:ACB) was down 2.5% on Wednesday . The company traded as low as C$4.70 and last traded at C$4.72. Approximately 188,396 shares changed hands during trading, a decline of 54% from the average daily volume of 412,234 shares. The stock had previously closed at C$4.84.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ACB. Canaccord Genuity Group set a C$10.00 price target on Aurora Cannabis and gave the stock a “buy” rating in a research report on Tuesday, January 27th. ATB Cormark Capital Markets lowered their price objective on Aurora Cannabis from C$9.00 to C$8.50 and set an “outperform” rating for the company in a research note on Thursday, December 11th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of C$9.25.

Aurora Cannabis Price Performance

The firm has a 50-day moving average of C$5.23 and a 200 day moving average of C$6.26. The company has a market capitalization of C$255.76 million, a PE ratio of -3.01 and a beta of 0.26. The company has a debt-to-equity ratio of 25.02, a current ratio of 3.06 and a quick ratio of 2.48.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.